[1] 王洪礼, 宁莉, 门昆, 魏殿军, WANG Hong-li, NING Li, MEN Kun, WEI Dian-jun. 老年高脂血症的临床诊断及其治疗进展 [J]. 医学综述 2010.doi:10.3969/j.issn.1006-2084.2010.04.036
[2] 孙春亮, 季兵, 付海波, 易仁元, 孙建广, 刘大庆. 脾切除对脂质代谢影响的临床研究 [J]. 肝胆胰外科杂志 2002.doi:10.3969/j.issn.1007-1954.2002.03.011
[3] 中国成人血脂异常防治指南制订联合委员会, Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. 中国成人血脂异常防治指南 [J]. 中华心血管病杂志 2007.doi:10.3760/j.issn:0253-3758.2007.05.003
[4] 张敏, 徐贵发, ZHANG Min, XU Gui-fa. 单纯高脂血症患者非药物干预的疗效评价 [J]. 山东大学学报（医学版） 2010.
[5] 陆再英, 钟南山, 谢毅. 内科学 [M]. 北京:人民卫生出版社 2008.
[6] MONROE V S, PARILAK L D, KERENSKY R A. Angiographic patterns and thenatural history of the vulnerable plague [J]. Progress in Cardio-vascular 2008, 31(05).
[7] Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. [J]. The Lancet 2005, 9493(9493).
[8] Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. [J]. The Lancet 2004, 9438(9438).
[9] NINOMIYA J K, L'ITALIENG, CRIQUI M H. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey [J]. Circulation 2004, 109.
[10] Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. [J]. Circulation: An Official Journal of the American Heart Association 2011, 20(20).
[11] Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg Hansen A, Watts GF. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. [J]. European Heart Journal: The Journal of the European Society of Cardiology 2011, 11(11).
[12] 王国良, 范建高. 临床脾脏病学 [M]. 北京:人民卫生出版社 2005.
[13] FATOUROS M, BOURANTAS K, BAIRAKTARIE. Role of the spleen in lipid metabotism [J]. British Journal of Surgery 1995, 82.
[14] AVIRAM M, BROOK J G, TATARSKY I. Increased low-density lipoprotein levels after splenectomy:a role for the spleen in cholesterol metabolism in myeloproliferative disorders [J]. American Journal of the Medical Sciences 1986, 291. |
